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ABSTRACT
Introduction: Patients undergoing coronary artery
bypass graft surgery often experience a range of
symptoms. Studies indicate that non-pharmacological
interventions such as exercise training and
psychoeducation have a positive physiological and
psychological effect in early outpatient rehabilitation. The
SheppHeartCABG trial will investigate the effect of early
comprehensive rehabilitation in early phase rehabilitation
versus usual care. The aim of this paper is to present the
protocol for the SheppHeartCABG trial.
Methods/analysis: SheppHeartCABG is an investigator-
initiated randomised clinical superiority trial with blinded
outcome assessment, employing 1:1 central
randomisation to rehabilitation plus usual care versus
usual care alone. On the basis of a sample size
calculation, 326 patients undergoing coronary artery
bypass grafting will be included from two clinical sites. All
patients receive usual care and patients allocated to the
experimental intervention follow 4 weeks rehabilitation
consisting of an exercise programme, psycho-educative
consultations and a compact mindfulness programme.
The primary outcome is physical function measured by
the 6-min walk test. The secondary outcomes are mental
health and physical activity measured by the Medical
Outcome Study Short Form (SF-12), anxiety and
depression measured by the Hospital Anxiety and
Depression Scale questionnaire, physical, emotional and
global scores by the HeartQoL questionnaire, sleep
measured by the Pittsburgh Sleep Quality Index, pain
measured by the Örebro Musculoskeletal Screening
Questionnaire and muscle endurance measured by the sit-
to-stand test. A number of explorative analyses will also
be conducted.
Ethics and dissemination: SheppHeartCABG is
approved by the regional ethics committee (no. H-4-
2014-109) and the Danish Data Protection Agency (no.
30-1309) and is performed in accordance with good
clinical practice and the Declaration of Helsinki in its latest
form. Positive, neutral and negative results of the trial will
be submitted to international peer-reviewed journals.
Furthermore, results will be presented at national and
international conferences relevant to the subject fields.
Trial registration number: NCT02290262; pre-results.
BACKGROUND
Following coronary artery bypass grafting
(CABG), patients often experience a range
of symptoms caused by the surgical proced-
ure and the ischaemic heart disease and the
subsequently return to everyday life is often
prolonged.1 Symptoms of anxiety and
depression peak before heart surgery and
again 2 weeks after and may persist up to
4 months after discharge.2 Pain, fatigue and
sleep disorders are common symptoms after
CABG and may be partly due to the lack of
postoperative physical activity.1 3 4 To tackle
these issues, cardiac rehabilitation is
recommended.5
Cardiac rehabilitation programmes are
generally described according to three main
phases: inpatient (phase I), early outpatient
(phase II) and long-term outpatient cardiac
rehabilitation (phase III).6 Rehabilitation
phase I normally ends 4 weeks following
CABG and ought to be followed by rehabili-
tation phase II.6 Enrolment in cardiac
rehabilitation after coronary revascularisation
positively impacts the psychological status of
Strengths and limitations of this study
▪ This study has been designed to meet the
criteria for high quality in a non-pharmacological
randomised clinical trial with computer-
generated randomisation, multicentre participa-
tion and blinded outcome assessment and
analysis.
▪ We are aware of the subjective nature of the self-
reported secondary outcomes. Accordingly, we
will interpret data conservatively.
▪ This trial is the first larger trial testing the effects
of a phase I comprehensive cardiac rehabilitation
programme after coronary artery bypass graft
surgery.
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patients and reduces cardiovascular mortality.7 More spe-
ciﬁcally, physical exercise in rehabilitation phase II has
positive effects on quality of life, exercise capacity, coron-
ary blood vessels, the myocardium, the endothelial func-
tion and coagulation.8–13 There are no randomised
clinical trials assessing cardiac rehabilitation pro-
grammes in phase I.
Non-pharmacological treatment potential
Open heart surgery is a severe physical and mental
strain. Indeed, cardiopulmonary bypass has a temporary
negative effect on physical functions.8 9 However, studies
show that psychosocial factors are also vital for patients’
prognosis in the short and longer term.10 The interven-
tions in phase I rehabilitation after CABG have either
investigated the physical or the psychological perspec-
tive. The effect of respiratory exercise preoperatively and
in the early postoperative period after CABG surgery has
been examined using different techniques.11–14 Trials
generally indicate a clinically signiﬁcant effect of respira-
tory physiotherapy, but these trials are small and include
selected trial populations. Cardiopulmonary bypass has a
temporary negative effect on the physical function
level.8 9 Examination of anxiety and depression in the
postoperative period is needed due to the limited power
and the use of non-validated instruments in the studies.2
Furthermore, it has been shown that a combination of a
psycho-educative intervention plus physical exercise has
a positive effect on physical and mental self-related
health.15 16 Mindfulness is a form of psychosocial inter-
vention that offers stress reduction, calm accepting
awareness and support of self-care through meditation-
based exercises. Until now, trials of mindfulness have
not been conducted in the context of CABG patients
but several trials with cardiovascular patients in other
contexts have shown reduction of perceived stress, pain,
depression, sleeping problems and anxiety.17–20
International guidelines recommend early mobilisa-
tion during hospitalisation, outpatient exercise training
and patient education after CABG.21 Since the symp-
toms related to CABG include a physical and a psycho-
logical component, it is plausible that patients with
CABG beneﬁt from a comprehensive rehabilitation
intervention.22 The SheppHeartCABG pilot trial was
initiated in 2013 to test the safety and tolerability of a
comprehensive intervention and to provide outcome
data for designing a larger trial.23 The pilot trial
included 60 patients and indicated the feasibility of phys-
ical and psycho-educational cardiac rehabilitation in
addition to sufﬁcient inclusion rate and high compli-
ance with most elements.23 The results were used to
modify the rehabilitation programme and optimise the
protocol and targeted outcomes.
In summary, there is evidence that physical exercise
beneﬁts heart patients’ rehabilitation associated with
open heart surgery. This part normally begins 2–4 weeks
after discharge, and the effects of early action are not
known. In addition, the positive effect of rehabilitation
may be stronger when physical exercise is combined
with a psychological intervention component.
TRIAL OBJECTIVES
The objective of the SheppHeartCABG trial is to investi-
gate the beneﬁts and harms of a phase I comprehensive
cardiac rehabilitation programme consisting of an exer-
cise training component and a psycho-educative compo-
nent, in addition to usual treatment in patients with
CABG. The primary hypothesis is that a comprehensive
rehabilitation programme improves the functional level
measured by a 6-min walk test (6MWT) by 30 m in the
experimental group compared with the control group.
The estimated increase in the primary outcome is a con-
servatively expected estimate based on the
SheppHeartCABG pilot trial, where we found a mean of
548 m in the intervention group receiving physical train-
ing and psycho-education versus a mean of 451 m in the
control group measured by 6MWT.23 The secondary
hypotheses are that a comprehensive rehabilitation pro-
gramme will improve: quality of life, sleep disorder, pain,
anxiety, depression and leg strength and endurance.
Exploratory analyses will evaluate whether the interven-
tion will have a positive impact on: fatigue, physical activ-
ity, cognitive and emotional representation of illness and
self-rated health.
METHODS
SheppHeartCABG is an investigator-initiated randomised
clinical superiority trial with a blinded outcome assess-
ment, employing 1:1 randomisation to a comprehensive
cardiac rehabilitation programme plus usual care versus
usual care alone. Patients will be recruited from two uni-
versity hospitals in Denmark. Figure 1 shows the trial
design.
Trial population and eligibility criteria
Patients aged 18 years and older admitted for elective
CABG who speak and understand Danish, and provide
written informed content, are considered eligible for
participation. Exclusion criteria are patients at inter-
mediate or high risk in relation to their cardiovascular
status24 and patients with orthopaedic conditions that
would prohibit walking and cycling exercise.
Experimental intervention
The experimental intervention is a comprehensive
rehabilitation programme with an exercise training com-
ponent and a psycho-educational component from
admission until 4 weeks after CABG surgery.
The physical components
The exercise programme during hospitalisation consists
of respiratory physiotherapy, neck and shoulder exer-
cises, walking and cycling. The purpose is preventing
respiratory complications such as atelectasis and pneu-
monia, neck and shoulder pain and increasing the
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physical functional level. Each exercise in the training
programme is based on guidelines,25 public health
recommendations for physical activity for adults26 and
supported by European recommendations for physical
training in patients with cardiac disease.21 27 Physical
exercise starts immediately after surgery and follows
the ACSM’s Guidelines for Exercise Testing and
Prescription.25 A physiotherapist with speciﬁc knowledge
of open heart surgery and cardiac rehabilitation initiates
the programme and gives the participants standardised
Figure 1 Trial design. CABG, coronary artery bypass grafting; HADS, Hospital Anxiety and Depression Scale; NYHA, New York
Heart Association; PSQI, Pittsburgh Sleep Quality Index.
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instructions in each part of the programme. All the com-
pletions of exercises are documented in the training
diary.
Physical exercises during hospitalisation
Breathing exercise
This consists of 7–10 deep breaths four times each day
when awake in daytime. Begin at admission and con-
tinue until hospital discharge.
Peak flow spirometry
Participants are encouraged to perform breathing exer-
cises consisting of 3–5 min of breathing in the PEP-ﬂute
four times daily during postoperative days 1 through 4.
Walking
Walking exercises are performed in the hallway at the
hospital ward on postoperative day 1 continuing to
4 weeks postsurgery. Walking exercise begins on the ﬁrst
postoperative day with a 2×5 min walk; second post-
operative day a 2×7 min walk; third postoperative day a
3×7 min walk and from the fourth postoperative day
until discharge a 3×10 min walk. The participant has to
increase the intensity of walking from low to moderate
during hospital admission.
Neck and shoulder
This consists of shoulder lifts, shoulder rolls and head
rolls with 10 sessions of each exercise two times per day
from postoperative day 1 until hospital discharge.
Cycling
Cycling exercise training is conducted on stationary
bicycles or alternatively using bed bikes.28 Heart rate
and saturation are monitored at three scheduled times
during the two ﬁrst exercise sessions. The participants
are encouraged to train using moderate intensity, so that
they are not exhausted and the training is safe and has
effect.29 Time for cycling will be 10 min. The rating of
perceived exertion scales (RPE) is used to measure the
exercise intensity. The cycling exercise intensity is at
RPE Borg between 13 and 15 on a scale of 6–20,30 and
the power on the cycle is programmed so that it matches
this intensity. There will be a 5 min warm-up and a
5 min cool-down to achieve cardiovascular adjustment
with exercise intensity ≤10 RPE Borg.31 32 The cycling
exercise consists of two daily sessions from the third post-
operative day until discharge.
Physical exercise from discharge to 4 weeks after surgery
Exercise training will take place at the participants’
home and outdoors including resistance training and
walking to obtain muscle strength and physical cap-
acity.33 At hospital, the physiotherapist introduces the
exercises and the training diary.
Walking
The length of daily walk will be increased from hospital
discharge until 4 weeks as follows: 3×10 min, 2×15 min,
2×20 min, 2×25 min and 2×30 min. The walking intensity
is moderate: the ﬁrst 2–3 min ≤10–13 on the Borg Scale
and the last 2–3 min at the same intensity level and the
time between 12 and 14 on the Borg Scale.
Leg endurance and strength
The participants perform a sit and stand exercise and
‘up on toes’ with 10 repetitions two times per day from
hospital discharge until 4 weeks after CABG.
The psycho-educational components
The interventions consist of four consultations: admis-
sion day, second postoperative day, discharge and
3 weeks after CABG. The ﬁrst three consultations are
in-hospital, and the fourth is by phone. The
psycho-educative intervention has two parts: one
inspired by the three dimensions in Rosemarie R Parse’s
‘Human Becoming Practice Methodologies’34 and the
second is a compact mindfulness programme combing
dialogue and recorded instructions for individual prac-
tice.35 The overall goal of the psycho-educative interven-
tion is that the patients learn to construe and react to
relevant physical and psychological symptoms and thus
learn to cope with anxiety and fear after CABG.
Consultations
Four consultations are scheduled: admission day, second
postoperative day, discharge and 3 weeks after CABG.
The ﬁrst three consultations are in-hospital, and the
fourth is by phone. The consultations are conducted by
specially trained nurses and last for about 45 min.
Rosemarie R Parse’s ‘Human Becoming Practice
Methodologies’34 forms the conceptual foundation for
the dialogues with the patients.
The Human becoming Practice Method describes
three dimensions for dialogue: (1) discuss and give
meaning to the past, present and future; (2) explore
and discuss events and opportunities and (3) pursue
imagined possibilities. According to this method, there
are three ways to make health changes: (1) using cre-
ative images to explore, (2) recognising personal pat-
terns and (3) value priorities and shed light on the
paradoxes by looking at the incongruence in a situation
and change the view of reality. The nurse is ‘truly
present’ in the process through discussion, silent immer-
sion and reﬂection.
Mindfulness
The other part of the psycho-educational intervention is
a set of mindfulness exercises that patients can use ad
libitum for stress reduction, calm awareness and self-care
through meditation-based exercises.17 36 For this trial, a
brief mindfulness intervention with several components
has been developed in cooperation with the Center for
Research in Existence and Society, University of
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Copenhagen. It particularly focuses on the patients with
CABG in need of calming down in physically and emo-
tionally stressful situations. At the ﬁrst consultation, par-
ticipants are introduced to mindfulness through a short
mindfulness exercise lead by the nurse, followed by a
dialogue. The participants receive an mp-3 player with
an audio mindfulness programme. The audio mindful-
ness programme consists of three guided meditations of
5 min, 15 min and 20 min, and the participants are
encouraged to listen to all three meditations from
admission to 4 weeks after CABG.
Usual care
Patient in both arms of the trial receive usual care
according to the guidelines.6 37 The standard admission
time after CABG is 5–8 days. Usual treatment involves
preoperative and postoperative information provided by
physicians, nurses and physiotherapists. Instructions
regarding precautions after sternotomy are provided by
physiotherapists covering the immediate postoperative
period during hospitalisation and after discharge.
Primary perioperative nursing consists of admission
interview with preoperative screening (falls, nutrition);
introduction to postoperative pain and nausea medica-
tions; pain assessment and postoperative activities. Early
postoperative care focuses on the observation of vital
signs, while the remainder of the hospital admission
focuses on recovery and preparation for discharge.
Outcomes and data collection
Data will be collected at admission, discharge and
4 weeks following surgery (see table 1).
Primary outcome
The primary outcome in this trial is physical functional
level as measured by the 6MWT. 6MWT is a simple tool
and will be administered at admission, discharge and
4 weeks following CABG.38 For the 6MWT, the participants
walked up and down a 30 m hallway for 6 min according
to the guidelines.39 To ensure standard testing, a standar-
dised instruction for patients has been developed.
Secondary outcomes
Furthermore, we will assess nine preplanned secondary
hypotheses based on estimates using the SDs from the
SheppHeartCABG pilot trial.23 The variables, instru-
ments, subscales, Cronbach’s α and hypothesised differ-
ences are detailed in table 2.
The Medical Outcome Study Short Form 12 (SF-12)
Mental health and physical health are measured by the
Medical Outcome Study Short Form 12 (SF-12) 4 weeks
after surgery. The SF-12 is a 12-item validated version of
the SF-36 and is a brief, reliable measure of overall
health status that generates a physical component score
and a mental component score (PCS and MCS).40
The Hospital Anxiety and Depression Scale
This 14-item instrument measures symptoms of anxiety
and depression41 42 The scale offers two scores HADS-A
and HADS-D, each of which can range from 0 to 21.
Scores of 0–7 for either subscale are regarded as
normal; 8–10 suggest the presence of a mood disorder
and 11 and above suggest the probable presence of a
mood disorder.
The HeartQol Questionnaire
Health-related quality of life is measured with the use of
the HeartQol questionnaire.43 The emotional subscale
and the global scale will be included which are scored
from 0 to 3. The questionnaire consists of 14 items.
Table 1 SheppHeartCABG: demographic and baseline characteristics, tests and questionnaires
Quantity
Time of
measure
Type of
quantity
Demographic
Age, height, weight, martial, educational Baseline Continuous
Occupational status Baseline Categorical
Smoking Baseline Binary (Y/N)
Clinical
Nutritional status (BMI) Baseline Continuous
NYHA calcification Baseline Continuous
Type of heart disease Baseline Categorical
Diabetes mellitus Baseline Binary (Y/N)
Medical status Baseline Categorical
Level of physical activity Baseline, discharge, W4 Continuous
Functional level
6MWT and Sit and stand test Baseline, discharge, W4 Continuous
Questionnaire
SF 12, HADS, ÖMPSQ, B-IPQ, EQ-5D Baseline, discharge, W4 Continuous
HeartQol, PSQI, MFI-20, IPAQ Baseline, W4 Continuous
BMI, body mass index; HADS, Hospital Anxiety and Depression Scale; 6MWT, 6-min walk test.
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The Pittsburgh Sleep Quality Index
This is a self-rated questionnaire which assesses quality and
disturbances of sleep over a 1-month time interval. Nineteen
items generate seven component scores. The sum of scores
for these seven components yields one global score.
The Örebro Musculoskeletal Screening Questionnaire
Pain is measured by the Örebro Musculoskeletal
Screening Questionnaire. This 25-item self-administered
questionnaire is formulated such that all musculoskeletal
pains are addressed and assessed in ﬁve categories.44
Sit-to-stand test
Strength and endurance in legs is measured by a
sit-to-stand test 4 weeks following surgery.45 The test is
carried out using a chair. The participants are then
seated on the chair and have to get up to full standing
position and then return to the initial seated position as
many times as possible in 30 s. The test will be per-
formed in accordance with guidelines.46
Exploratory outcomes
Clinical and demographic data will be evaluated. The
HeartQol physical component will be analysed as an
exploratory outcome.43 Furthermore, a series of ques-
tionnaires regarding fatigue, physical activity and percep-
tion of illness are administered. The Measurement of
Fatigue Instrument47–50 is a 20 item self-report instru-
ment designed to measure fatigue. The International
Physical Activity Questionnaire51 is used to measure
health-related physical activity. Perception of illness is
measured by The Brief perception Questionnaire,52
which is a short questionnaire that assesses cognitive and
emotional representations of illness on the basis of eight
items. The EQ-5D is a standardised instrument for use
as a measure of current health status that provides a
simple descriptive proﬁle and a single index value that
can be used in clinical and economic evaluation of
healthcare and in population health surveys.53
Sample size and power calculations
The study is a randomised superiority trial with the
continuous outcome 6MWT with 1 control per experi-
mental participant. In the pilot trial, the outcome was
normally distributed with an SD of 90 m. If the true dif-
ference in the experimental and control means is 30 m,
the trial shall include 163 experimental participants and
163 control participants (total participants 326) to be
Table 2 Overview of secondary outcomes
Variables Instrument Subscales
Cronbach’s
alpha
Hypothesised difference
(anticipated power)
Health status Medical Outcome Study Short
Form 12 (SF-12)
Physical Component
Summary (PCS) [0–100]
Mental Component
Summary (MCS) [0–100]
0.87
0.84
2.4 (97%)
8.21(100%)
Anxiety—
depression
Hospital Anxiety and
Depression Scale (HADS)41 42
HADS-A scale [0–21]
HADS-D scale [0–21]
0.83
0.82
1.26 (86%)
4.3 (100%)
Quality of life HeartQol questionnaire43 57 The emotional subscales
[0–3]
The global subscales [0–3]
0.80–0.91
0.80–0.91
0.3 (85%)
0.2 (95%)
Sleep Pittsburgh Sleep Quality Index
(PSQI)58
Component 1: Subjective
sleep quality score [0–3]
Component 2: Sleep
latency score [0–3]
Component 3: Sleep
duration score [0–3]
Component 4: Habitual
sleep efficiency score [0–3]
Component 5: Step
disturbances score[0–3]
Component 6: Use of
sleeping medication score
[0–3]
Component 7: Daytime
dysfunction score [0–3]
Global PQSI score [0–21]
0.83 2.2 (96%)
Pain Örebro Musculoskeletal Pain
Questionnaire (OMPQ)44
OMPQ total score [0–210] 0.86 10.2 (98%)
Strength and
endurance in legs
Sit-to-stand test39 Total number of repetitions NR 3.6 (100%)
HADS, Hospital Anxiety and Depression Scale; NR, not reported.
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able to reject the null hypothesis that the population
means of the experimental and control groups are equal
with probability (power) 85%. The type I error probabil-
ity associated with this test of this null hypothesis is 5%.
Based on SheppHeartCABG the pilot trial, several of
the secondary outcomes are overpowered as shown pre-
viously. For all outcomes except HeartQol physical, the
power to reject the null hypothesis was above 85% (type
I error 5%) (see table 2).
Study procedure and randomisation
To achieve our estimated sample size of 326 participants,
patients will be identiﬁed and screened consecutively
from the current elective CABG waiting list. Patients
similar to the New York Heart Association (NYHA)
groups I–III and without physical illness which prevents
physical exercise are suitable participants in the trial.
Verbal information will be given to the patient on admis-
sion day and is planned so it is possible for relatives to
participate by staff personal. If a patient accepts to par-
ticipate after verbal and written informed consent, the
patient is randomised to the rehabilitation plus usual
care or usual care alone. The allocation sequence is
computer generated with a varying block size concealed
by the investigators. The allocation will be conducted
centrally using the web-based ‘Copenhagen Trial Unit
Online Randomisation System’, and selected relevant
participant information will be registered (civil registra-
tion number (CPR), participant number and stratum).
Stratiﬁcation variables are Rigshospitalet, University of
Copenhagen and Odense Universitetshospital,
University of Southern Denmark and sex. After alloca-
tion, the investigator immediately informs the patient of
the result and the further plan. For both groups,
follow-up assessments including physical tests and ques-
tionnaires will take place at admission, discharge and
4 weeks following surgery. Questionnaires will be com-
pleted on paper or electronically in the questionnaire
system Enalyzer. Data management is handled independ-
ently from the researchers who interpret the data. All
data are stored electronically in a coded database and in
an independent spreadsheet, which is only accessible by
the SheppHeart staff. The recruitment process will con-
tinue until 326 patients have been included.
Blinding
It is not possible to blind the interventions to the staff
and patients. However, all physical tests, data collection
and data management will be conducted by staff
blinded to the interventions. Statistical analyses and
drawing of conclusions from these will also be con-
ducted blinded to the intervention group.
Statistical analysis
Analysis of primary and secondary outcomes
The primary and all secondary outcomes are continu-
ous. For all primary and secondary outcomes except
HeartQol and HADS, it is expected that the scores will
be normally distributed.
Analyses will be intention-to-treat analyses using two-
sided tests with a signiﬁcance level of 5%. There are two
types of comparison between the intervention groups: (1)
comparison of values measured at week 4 and (2) com-
parison of values measured at discharge and at 4 weeks. In
the ﬁrst type, a general univariate linear model is used
(except for HeartQol and HADS (see below)), adjusted
for baseline values. In the second type (except for
HeartQol and HADS (see below)), a mixed linear model
including an unstructured covariance matrix is used. In
this model, the interaction between intervention and time
is of main interest. If assumptions of the models are not
fulﬁlled with reasonable approximation, non-parametric
sensitivity tests will be performed.
HeartQol quantities are converted to binary quantities
based on the median score, and logistic regression is
used to compare the two groups at 4 weeks adjusted for
value at baseline. HADS is reported as mean (SD) and is
converted to binary quantities expressed as probable
anxiety and depression (scores≥8). Logistic regression is
used to compare the intervention and control groups at
4 weeks adjusted for value at baseline.
Since almost all secondary outcomes are overpowered,
Cohen’s d will be calculated for each outcome to test
the clinical effect. SAS V.9.3 will be used.
Missing values and multiplicity
For the primary and secondary outcomes, multiple
imputation (MI) of missing values using the Markov
Chain Monte Carlo (MCMC) approach will be per-
formed if the number of incomplete participants is
above 5%. The variables included are the group mem-
bership, stratifying variables (site and sex), time (base-
line, discharge and 4 weeks after discharge) and
outcomes. If MI is used, the primary result will be that
based on the multiply imputed data sets. Signiﬁcant
(adjusted p<0.05) results of the primary and secondary
outcomes will be supplemented by the following worst
case sensitivity analysis. Let A be the group where a
beneﬁcial signiﬁcant effect is observed and B be the
other group. Missing values in group A will be imputed
by the minimum value found in the material, and
missing values in group B will be imputed by the
maximum value found. When the treatment code is
broken, the results may be interpreted.
The primary outcome (6MWT) will ﬁrst be tested
using a signiﬁcance level of 0.05. Analyses of the second-
ary outcome measures as preplanned in the protocol
will be analysed with no adjustment of p values due to
multiplicity. Instead, the interpretation of each second-
ary outcome measure will be assessed in the light of mul-
tiple testing, that is, statistically signiﬁcant effects will be
interpreted in the context of increased risk of type-I
error. No signiﬁcance testing will be performed for the
explorative outcomes.
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In addition to the primary intention-to-treat analysis,
we will also perform a per-protocol analysis to include
information on adherence to the intervention in the
intervention group.54 The per-protocol deﬁnition reﬂects
the two components of the intervention, in that patients
in the intervention group must have completed 75% per
cent of the programme in the per-protocol analysis.
Ethics, safety and dissemination
The trial will be conducted according to the latest
Declaration of Helsinki. It has been registered at
ClinicalTrials.gov no NCT02290262 before inclusion of
the ﬁrst participant. Information about the trial is given
verbally and in writing. Eligible patients will be enrolled
as trial participants. Trial participants are free to with-
draw their informed consent at any time and will be
treated according to the department’s standard proce-
dures. Patients who leave the trial will be asked for per-
mission to continue to collect data and to use already
collected data. If the patient gives permission, data will
be included in the ﬁnal analysis. If a patient refuses the
use of already collected data, all related data will be
destroyed. The trial will be conducted according to Act.
No. 593 of 14 June 2011 on Act on Research Ethics
Review of Health Research Projects. The investigator will
immediately notify the regional ethics committee if,
within the interventions period, there occur serious
adverse events or serious adverse reactions. An inde-
pendent Data Monitoring and Safety Committee
(DMSC) has been established.
Safety
Throughout the trial, annual reports including all
expected or unexpected adverse events or reactions will
be submitted to the ethical committee. Reports will be
accompanied by an assessment of the participants’
safety. The investigator notiﬁes the committee within
90 days of completion of the trial.
Dissemination plan
Positive, neutral and negative results of the trial will be
submitted to international peer-reviewed journals.
Furthermore, results will be presented at national and
international conferences relevant to the subject ﬁelds.
Authorship will be allocated using the guidelines for
authorship deﬁned by the International Committees of
Medical Journal Editors and depends on personal
involvement. Ethic Committees and component author-
ities will be able to obtain direct access to data and
documentation.
DISCUSSION
This SheppHeartCABG trial, assessing the effect of a
comprehensive cardiac rehabilitation in phase I rehabili-
tation on a population undergoing CABG, is the ﬁrst ran-
domised clinical trial in a representative population. This
trial is expected to contribute results that can improve
patient outcomes related to ischaemic heart disease
treated by CABG and early rehabilitation. This is the ﬁrst
trial to test the effect of a comprehensive rehabilitation
programme in rehabilitation phase I after CABG.
SheppHeartCABG has been designed to meet the criteria
for high quality in a non-pharmacological clinical trial
with central stratiﬁed randomisation and two centre par-
ticipation which secures against selection bias.55 56
The primary outcome and all statistical analysis are
blinded to intervention, which should reduce detection
and interpretation bias.55 56
Trajectory
Inclusion was initiated on November 2014 and is
expected to continue until July 2016.
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